Trial Profile
Efficacy and safety of peptide 277 in attentuating beta cell destruction in children with newly diagnosed type 1 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Peptide p277 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.